rs3219433

Variant summary

Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong

The NM_002691.4(POLD1):​c.2718-12A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0087 ( 0 hom., cov: 0)
Exomes 𝑓: 0.000032 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

POLD1
NM_002691.4 intron

Scores

2
Splicing: ADA: 0.00001998
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.90

Publications

10 publications found
Variant links:
Genes affected
POLD1 (HGNC:9175): (DNA polymerase delta 1, catalytic subunit) This gene encodes the 125-kDa catalytic subunit of DNA polymerase delta. DNA polymerase delta possesses both polymerase and 3' to 5' exonuclease activity and plays a critical role in DNA replication and repair. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 6. [provided by RefSeq, Mar 2012]
POLD1 Gene-Disease associations (from GenCC):
  • POLD1-related polyposis and colorectal cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • colorectal cancer, susceptibility to, 10
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • mandibular hypoplasia-deafness-progeroid syndrome
    Inheritance: AD, AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp, Ambry Genetics, Orphanet, G2P
  • Polymerase proofreading-related adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency 120
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • non-severe combined immunodeficiency due to polymerase delta deficiency
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POLD1NM_002691.4 linkc.2718-12A>C intron_variant Intron 21 of 26 ENST00000440232.7 NP_002682.2 P28340A0A024R4F4Q59FA0

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POLD1ENST00000440232.7 linkc.2718-12A>C intron_variant Intron 21 of 26 1 NM_002691.4 ENSP00000406046.1 P28340
ENSG00000142539ENST00000599632.1 linkc.-88A>C upstream_gene_variant 5 ENSP00000473233.1 M0R3H8

Frequencies

GnomAD3 genomes
AF:
0.00873
AC:
533
AN:
61056
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.00316
Gnomad AMI
AF:
0.0145
Gnomad AMR
AF:
0.00830
Gnomad ASJ
AF:
0.00781
Gnomad EAS
AF:
0.00226
Gnomad SAS
AF:
0.00341
Gnomad FIN
AF:
0.0159
Gnomad MID
AF:
0.00794
Gnomad NFE
AF:
0.0209
Gnomad OTH
AF:
0.00358
GnomAD2 exomes
AF:
0.000169
AC:
20
AN:
118132
AF XY:
0.000155
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000500
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000117
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000221
Gnomad OTH exome
AF:
0.000595
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000323
AC:
29
AN:
896936
Hom.:
0
Cov.:
30
AF XY:
0.0000246
AC XY:
11
AN XY:
446350
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
28984
American (AMR)
AF:
0.0000363
AC:
1
AN:
27566
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15844
East Asian (EAS)
AF:
0.00
AC:
0
AN:
19430
South Asian (SAS)
AF:
0.0000619
AC:
4
AN:
64652
European-Finnish (FIN)
AF:
0.000108
AC:
2
AN:
18436
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2594
European-Non Finnish (NFE)
AF:
0.0000322
AC:
22
AN:
683740
Other (OTH)
AF:
0.00
AC:
0
AN:
35690
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.230
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00871
AC:
533
AN:
61182
Hom.:
0
Cov.:
0
AF XY:
0.00824
AC XY:
246
AN XY:
29842
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00315
AC:
100
AN:
31764
American (AMR)
AF:
0.00830
AC:
43
AN:
5182
Ashkenazi Jewish (ASJ)
AF:
0.00781
AC:
9
AN:
1152
East Asian (EAS)
AF:
0.00225
AC:
4
AN:
1776
South Asian (SAS)
AF:
0.00341
AC:
8
AN:
2344
European-Finnish (FIN)
AF:
0.0159
AC:
27
AN:
1696
Middle Eastern (MID)
AF:
0.00877
AC:
1
AN:
114
European-Non Finnish (NFE)
AF:
0.0208
AC:
334
AN:
16022
Other (OTH)
AF:
0.00350
AC:
3
AN:
856
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.268
Heterozygous variant carriers
0
58
117
175
234
292
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000212
Hom.:
488

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Oct 08, 2015
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2718-12A>C intronic alteration consists of a A to C substitution 12 nucleotides before coding exon 21 in the POLD1 gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.40
DANN
Benign
0.65
PhyloP100
-1.9
PromoterAI
0.043
Neutral
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000020
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3219433; hg19: chr19-50918969; API